A Multi-center, Randomized, Double-blind Study to Compare the Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea (CDAD).
Phase of Trial: Phase III
Latest Information Update: 24 Apr 2018
At a glance
- Drugs Cadazolid (Primary) ; Vancomycin
- Indications Clostridium difficile infections
- Focus Registrational; Therapeutic Use
- Acronyms IMPACT 2
- Sponsors Actelion Pharmaceuticals
- 24 Apr 2018 Results from IMPACT 1 and IMPACT 2 studies, presented at the 28th European Congress of Clinical Microbiology and Infectious Diseases
- 12 May 2017 Status changed from active, no longer recruiting to completed.
- 19 Apr 2017 Planned End Date changed from 1 Apr 2017 to 10 May 2017.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History